GLENMEDE TRUST CO NA
BankPosition in TEVA — Teva Pharmaceutical Industries Ltd
CIK 314949
PHILADELPHIA, PA
Position in TEVA
as of Mar 31, 2026
· filed May 26, 2026
Position Value
$1,607,715
+$1,323,580 QoQ
Shares Held
53,377
+486.3% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
5 quarters on record
Voting authority
Sole 7.668096745789385.ToString("F0")%
Shared 0.ToString("F0")%
None 92.33190325421062.ToString("F0")%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026GLENMEDE TRUST CO NA holds $85,307,293 across 13 Drug Manufacturers - Specialty & Generic names. TEVA ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
231,874 | $27,409,824 | |
| 2 | ALKS |
Alkermes plc.
|
378,090 | $13,369,261 | |
| 3 | PBH |
Prestige Consumer Healthcare Inc.
|
212,461 | $12,592,562 | |
| 4 | SUPN |
Supernus Pharmaceuticals, Inc.
|
219,099 | $11,325,226 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
78,577 | $10,351,733 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
8,052 | $4,774,674 | |
| 7 | ELAN |
Elanco Animal Health Inc
|
80,571 | $1,928,063 | |
| 8 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
53,377 | $1,607,715 |
All Filings in TEVA
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,607,715 | 53,377 | Shares | Sole | 2026-05-26 | |
| 2025-12-31 | $284,135 | 9,104 | Shares | Sole | 2026-02-17 | |
| 2020-09-30 | $19,145 | 2,125 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $25,695 | 2,084 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $22,503 | 2,506 | Shares | Defined | 2020-05-20 | |
| No filing history on record for this holder in this stock. | ||||||